Prevalence and influencing factors of spirometry examination among residents aged 40 years and older in Inner Mongolia Autonomous Region – a cross-sectional survey

Autor: Huimin LIU, Min ZHANG, Wenjie CHEN, Liying QIAO, Yonggang QIAN, Chunxia HUI

Publikováno v: Zhongguo gonggong weisheng, Vol 39, Iss 11, Pp 1388-1391 (2023)

ObjectiveTo examine the prevalence and influencing factors of spirometry examination among residents aged ≥ 40 years in Inner Mongolia Autonomous Region (Inner Mongolia) for promoting prevention and control of chronic respiratory diseases. MethodsU

Externí odkaz: https://doaj.org/article/e69a89a504d84c9781c6c66705a3005f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Micro-phenomenological approach to explore the patient experience during an initial spirometry examination to diagnose COPD in general practice in France

Autor: Laurent Plantier, Matthieu Bremond, Anthony Berthelot, Hervé Breton, Maxime Pautrat

Publikováno v: BMJ Open, Vol 11, Iss 7 (2021)

Objectives To explore the patient experience of a spirometry test used to confirm chronic obstructive pulmonary disease (COPD) diagnosis in patients with suspected smoking-related COPD.Design This is a qualitative study, performed with open interview

Externí odkaz: https://doaj.org/article/df79216e3fb74f079791aa97ae9f6791

Can the Arab population in Sweden undergo spirometry examination with Swedish reference values?

Autor: Ibrahim Yousef, Iman

Spirometry is a lung function test, used to diagnose for example asthma and chronic obstructive pulmonary disease. The reference values for spirometry are determined by gender, height, age, and ethnicity. Swedish references are used for all patients

Externí odkaz: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-477439

[Analyses of the rate of spirometry examination and its related factors in chronic obstructive pulmonary diseasepatients aged 40 years or older in China, 2014-2015].

Autor: Lyu XL; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Cong S; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Fan J; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Zhang Y; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Wang N; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Bao HL; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Wang BH; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Wang Q; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Wang LH; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China., Fang LW; National Center for Chronic and Non-communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Publikováno v: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi [Zhonghua Liu Xing Bing Xue Za Zhi] 2020 May 10; Vol. 41 (5), pp. 672-677.